Total cost of care for patients whose glycated hemoglobin levels were
James W. Davis, PhD
Advertisement
Articles by James W. Davis, PhD
Adherence was examined among patients taking medications, individually and in combinations, to treat hypertension, hyperlipidemia, and/or diabetes.
Among insured patients with type 2 diabetes, copayments and glycosylated hemoglobin values were associated with increased rates of drug switching.
Advertisement
Latest Updated Articles
- Copayment Level and Drug Switching: Findings for Type 2 Diabetes
Published: January 8th 2011 | Updated:
- Adherence With Lipid-Lowering, Antihypertensive, and Diabetes Medications
Published: June 14th 2011 | Updated:
- Association Between Sustained Glycated Hemoglobin Control and Healthcare Costs
Published: April 8th 2013 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Expert Discusses Logistical Considerations and Future Research Needs for Radiopharmaceuticals
2
Zongertinib Shows Clinically Meaningful Efficacy in Advanced HER2-Mutant NSCLC
3
A Common Virus May Hold New Clues to Lupus
4
SHR-A1811 Plus Pertuzumab Improves Survival in HER2-Positive Metastatic Breast Cancer
5
